Skip to content
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma

Authors not listed

Hexagon Therapies, LLC · 2018

Chronic inflammation Human Randomized controlled trial
＋ Sign in to save

Abstract

This study aims to look at whether human umbilical cord blood plasma (HUCBP) is safe for intravascular (iv) administration; and whether it provides any reversal of frailty or other age-related biological measures.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-20 MST

Cite this

APA
Anonymous. (2018). Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma. <em>Hexagon Therapies, LLC</em>. https://clinicaltrials.gov/study/NCT03229785
Vancouver
Anonymous. Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma. Hexagon Therapies, LLC. 2018.
BibTeX
@misc{anon2018Determ, title = {Determining Overall Improvement in the Quality of Life of Individuals Receiving Human Umbilical Cord Blood Plasma}, author = {Anonymous}, journal = {Hexagon Therapies, LLC}, year = {2018}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings